Concepedia

Fosun Pharma (China)

FP

Statistics

Publications

462

Citations

14.1K

Authors

21

Location

Shanghai, China

Fosun Pharma (China) is a company institution in Shanghai, China known for life sciences, medicine, and oncology.

HomepageROR

Top concepts

Publications

462

Maximizing Synthetic Efficiency: Multi-Component Transformations Lead the Way

Hugues Bienaymé, Chris Hulme, G. ODDON et al. · Chemistry - A European Journal · 2000 · 1.1K citations · Full text

, , +17

Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Susan E. Logue, Eoghan P. McGrath, Patricia A. Cleary et al. · Nature Communications · 2018 · 290 citations · Full text

, , +16

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer

Na Zhao, Jin Cao, Longyong Xu et al. · Journal of Clinical Investigation · 2018 · 260 citations · Full text

, , +17

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Xia Sheng, Hatice Zeynep Nenseth, Su Qu et al. · Nature Communications · 2019 · 233 citations · Full text

, , +16

Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs

Nicola Colclough, Kan Chen, Peter Johnström et al. · Clinical Cancer Research · 2020 · 233 citations · Full text

, , +15

1–5 of 462

Authors

21

  1. QZ
    Qingping Zeng

    Fosun Pharma (China), China

    58 publications · 2.1K citations

    19

    h-index

  2. ZW
    Zhuli Wu

    Fosun Pharma (China), China

    42 publications · 146 citations

    6

    h-index

  3. LD
    Lei Diao

    Fosun Pharma (China), China

    25 publications · 83 citations

    5

    h-index

  4. XZ
    Xingdong Zhao

    Fosun Pharma (China), China

    7 publications · 79 citations

    5

    h-index

  5. YT
    Yan Tan

    Fosun Pharma (China), China

    17 publications · 93 citations

    5

    h-index

1–5 of 21